Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma
NCT01833767
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No participants enrolled
Conditions
Metastatic Melanoma
Interventions
DRUG:
Cyclophosphamide and Interleukin 2
Sponsor
Western Regional Medical Center